Retinoids: present role and future potential

被引:161
作者
Evans, TRJ [1 ]
Kaye, SB [1 ]
机构
[1] Univ Glasgow, Crc Dept Med Oncol, Glasgow G61 1BD, Lanark, Scotland
关键词
differentiation; apoptosis; drug resistance; retinoids;
D O I
10.1038/sj.bjc.6690312
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Vitamin A and its biologically active derivatives, retinal and retinoic acid (RA), together with a large repertoire of synthetic analogues are collectively referred to as retinoids. Naturally occurring retinoids regulate the growth and differentiation of a wide variety of cell types and play a crucial role in the physiology of vision and as morphogenic agents during embryonic development. Retinoids and their analogues have been evaluated as chemoprevention agents, and also in the management of acute promyelocytic leukaemia. Retinoids exert most of their effects by binding to specific receptors and modulating gene expression. The development of new active retinoids and the identification of two distinct families of retinoid receptors has led to an increased understanding of the cellular effects of activation of these receptors. In this article we review the use of retinoids in chemoprevention strategies, discuss the cellular consequences of activated retinoid receptors, and speculate on how our increasing understanding of retinoid-induced signalling pathways may contribute to future therapeutic strategies in the management of malignant disease.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 133 条
[1]   RETINOIC ACID RECEPTORS AND RETINOID X-RECEPTORS - INTERACTIONS WITH ENDOGENOUS RETINOIC ACIDS [J].
ALLENBY, G ;
BOCQUEL, MT ;
SAUNDERS, M ;
KAZMER, S ;
SPECK, J ;
ROSENBERGER, M ;
LOVEY, A ;
KASTNER, P ;
GRIPPO, JF ;
CHAMBON, P ;
LEVIN, AA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (01) :30-34
[2]  
ANZANO MA, 1994, CANCER RES, V54, P4614
[3]   PHASE-II TRIAL OF 13-CIS-RETINOIC ACID PLUS INTERFERON-ALPHA IN NON-SMALL-CELL LUNG-CANCER [J].
ARNOLD, A ;
AYOUB, J ;
DOUGLAS, L ;
HOOGENDOORN, P ;
SKINGLEY, L ;
GELMON, K ;
HIRSH, V ;
EISENHAUER, E .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (04) :306-309
[4]   APOPTOSIS DURING RETINOIC ACID-INDUCED DIFFERENTIATION OF F9 EMBRYONAL CARCINOMA-CELLS [J].
ATENCIA, R ;
GARCIASANZ, M ;
UNDA, F ;
ARECHAGA, J .
EXPERIMENTAL CELL RESEARCH, 1994, 214 (02) :663-667
[5]   PREVENTION OF SKIN-CANCER AND REDUCTION OF KERATOTIC SKIN-LESIONS DURING ACITRETIN THERAPY IN RENAL-TRANSPLANT RECIPIENTS - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY [J].
BAVINCK, JNB ;
TIEBEN, LM ;
VANDERWOUDE, FJ ;
TEGZESS, AM ;
HERMANS, J ;
TERSCHEGGET, J ;
VERMEER, BJ .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (08) :1933-1938
[6]   PREVENTION OF 2ND PRIMARY TUMORS WITH ISOTRETINOIN IN PATIENTS WITH SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - LONG-TERM FOLLOW-UP [J].
BENNER, SE ;
PAJAK, TF ;
LIPPMAN, SM ;
EARLEY, C ;
HONG, WK .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (02) :140-141
[7]  
BERTRAM JS, 1983, CANCER SURV, V2, P243
[8]   PREVENTION OF 2ND PRIMARY TUMORS WITH ETRETINATE IN SQUAMOUS-CELL CARCINOMA OF THE ORAL CAVITY AND OROPHARYNX - RESULTS OF A MULTICENTRIC DOUBLE-BLIND RANDOMIZED STUDY [J].
BOLLA, M ;
LEFUR, R ;
VAN, JT ;
DOMENGE, C ;
BADET, JM ;
KOSKAS, Y ;
LAPLANCHE, A .
EUROPEAN JOURNAL OF CANCER, 1994, 30A (06) :767-772
[9]  
BOLLAG W, 1994, LEUKEMIA, V8, pS11
[10]   Multifactorial mechanism for the potentiation of cisplatin (CDDP) cytotoxicity by all-trans retinoic acid (ATRA) in human ovarian carcinoma cell lines [J].
Caliaro, MJ ;
Vitaux, P ;
Lafon, C ;
Lochon, I ;
Nehme, A ;
Valette, A ;
Canal, P ;
Bugat, R ;
Jozan, S .
BRITISH JOURNAL OF CANCER, 1997, 75 (03) :333-340